We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
VFA
151
Virtus Fund Advisers
Connecticut
$97.5M -$5.12M -91,218 -5%
ACI
152
AMP Capital Investors
Australia
$97.3M -$6.15M -109,470 -6%
USSCPF
153
United States Steel & Carnegie Pension Fund
New York
$92.5M
SOMRS
154
State of Michigan Retirement System
Michigan
$91.1M -$1.29M -22,951 -1%
Caisse de Depot et Placement du Quebec (CDPQ)
155
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$90.5M -$4.25M -75,666 -5%
Korea Investment Corp
156
Korea Investment Corp
South Korea
$90.1M -$10.6M -188,430 -11%
Aviva
157
Aviva
United Kingdom
$89.1M -$1.52M -27,141 -2%
EPFB
158
Employees Provident Fund Board
Malaysia
$88.5M -$1.94M -34,585 -2%
TAM
159
Tocqueville Asset Management
New York
$88.3M +$3.88K +69 +0%
EA
160
Euclid Advisors
Connecticut
$87M +$4.65M +82,834 +6%
Neuberger Berman Group
161
Neuberger Berman Group
New York
$86.6M -$1.88M -33,492 -2%
SC
162
SRB Corp
Massachusetts
$85.7M
AI
163
Analytic Investors
California
$84.8M -$30.3M -539,089 -26%
MSA
164
Mason Street Advisors
Wisconsin
$84.8M +$19M +338,308 +29%
Nomura Asset Management
165
Nomura Asset Management
Japan
$84.1M +$1.01M +17,937 +1%
N
166
Nuveen
North Carolina
$83.7M -$158K -2,815 -0.2%
BMO
167
Beck Mack & Oliver
New York
$83.3M -$2.31M -41,092 -3%
Los Angeles Capital Management
168
Los Angeles Capital Management
California
$82.3M +$28.8M +512,465 +54%
GC
169
Guggenheim Capital
Illinois
$82.2M +$3.4M +60,572 +4%
EAM
170
Eagle Asset Management
Florida
$81.5M +$4.31M +76,723 +6%
DekaBank Deutsche Girozentrale
171
DekaBank Deutsche Girozentrale
Germany
$79.5M +$7M +124,636 +10%
1832 Asset Management
172
1832 Asset Management
Ontario, Canada
$78.1M -$16.1M -286,284 -17%
ASRS
173
Arizona State Retirement System
Arizona
$77.6M -$2.86M -50,933 -4%
Nordea Investment Management
174
Nordea Investment Management
Sweden
$77.3M +$4.58M +81,535 +6%
CIC
175
Crawford Investment Counsel
Georgia
$76.8M +$2.61M +46,512 +4%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.